Kezar Life Sciences, Inc. (KZR)
7.29
0.00 (0.00%)
USD |
NASDAQ |
Jun 10, 16:00
Kezar Life Sciences Accounts Payable (Quarterly) : 0.273M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.273M |
| December 31, 2025 | 0.507M |
| September 30, 2025 | 0.911M |
| June 30, 2025 | 1.157M |
| March 31, 2025 | 1.966M |
| December 31, 2024 | 3.651M |
| September 30, 2024 | 3.461M |
| June 30, 2024 | 2.263M |
| March 31, 2024 | 5.059M |
| December 31, 2023 | 8.251M |
| September 30, 2023 | 3.12M |
| June 30, 2023 | 2.492M |
| March 31, 2023 | 4.136M |
| December 31, 2022 | 2.479M |
| September 30, 2022 | 2.274M |
| June 30, 2022 | 1.922M |
| March 31, 2022 | 1.359M |
| Date | Value |
|---|---|
| December 31, 2021 | 2.028M |
| September 30, 2021 | 1.543M |
| June 30, 2021 | 1.633M |
| March 31, 2021 | 3.578M |
| December 31, 2020 | 2.358M |
| September 30, 2020 | 1.285M |
| June 30, 2020 | 1.007M |
| March 31, 2020 | 1.583M |
| December 31, 2019 | 0.823M |
| September 30, 2019 | 0.824M |
| June 30, 2019 | 0.955M |
| March 31, 2019 | 1.448M |
| December 31, 2018 | 0.193M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.717M |
| December 31, 2017 | 0.547M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| NovelStem International Corp. | 0.00 |
| Brainstorm Cell Therapeutics, Inc. | 7.317M |
| Summit Therapeutics, Inc. | 27.55M |
| Protara Therapeutics, Inc. | 4.031M |
| Clene, Inc. | 1.309M |